vs
礼来(RNA)与SOLAI Ltd(SLAI)财务数据对比。点击上方公司名可切换其他公司
礼来的季度营收约是SOLAI Ltd的1.1倍($12.5M vs $11.0M),SOLAI Ltd净利率更高(-126.2% vs -1398.3%,领先1272.1%),礼来同比增速更快(434.0% vs -43.1%),SOLAI Ltd自由现金流更多($-17.0M vs $-156.9M)
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业,在18个国家设有办事处,产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立,品牌名即取自创始人姓名。
RNA vs SLAI — 直观对比
营收规模更大
RNA
是对方的1.1倍
$11.0M
营收增速更快
RNA
高出477.1%
-43.1%
净利率更高
SLAI
高出1272.1%
-1398.3%
自由现金流更多
SLAI
多$139.9M
$-156.9M
损益表 — Q3 FY2025 vs Q2 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $12.5M | $11.0M |
| 净利润 | $-174.4M | $-13.9M |
| 毛利率 | — | 0.1% |
| 营业利润率 | -1513.5% | -126.2% |
| 净利率 | -1398.3% | -126.2% |
| 营收同比 | 434.0% | -43.1% |
| 净利润同比 | -117.0% | -173.4% |
| 每股收益(稀释后) | $-1.27 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
RNA
SLAI
| Q3 25 | $12.5M | — | ||
| Q2 25 | $3.8M | $11.0M | ||
| Q1 25 | $1.6M | — | ||
| Q4 24 | $3.0M | — | ||
| Q3 24 | $2.3M | — | ||
| Q2 24 | $2.0M | $19.4M | ||
| Q1 24 | $3.5M | — | ||
| Q4 23 | $2.2M | — |
净利润
RNA
SLAI
| Q3 25 | $-174.4M | — | ||
| Q2 25 | $-157.3M | $-13.9M | ||
| Q1 25 | $-115.8M | — | ||
| Q4 24 | $-102.3M | — | ||
| Q3 24 | $-80.4M | — | ||
| Q2 24 | $-70.8M | $18.9M | ||
| Q1 24 | $-68.9M | — | ||
| Q4 23 | $-60.4M | — |
毛利率
RNA
SLAI
| Q3 25 | — | — | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 52.4% | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
营业利润率
RNA
SLAI
| Q3 25 | -1513.5% | — | ||
| Q2 25 | -4448.7% | -126.2% | ||
| Q1 25 | -8360.9% | — | ||
| Q4 24 | -4069.6% | — | ||
| Q3 24 | -4200.9% | — | ||
| Q2 24 | -4040.4% | -2.6% | ||
| Q1 24 | -2178.6% | — | ||
| Q4 23 | -3043.5% | — |
净利率
RNA
SLAI
| Q3 25 | -1398.3% | — | ||
| Q2 25 | -4089.3% | -126.2% | ||
| Q1 25 | -7360.0% | — | ||
| Q4 24 | -3439.5% | — | ||
| Q3 24 | -3441.7% | — | ||
| Q2 24 | -3461.8% | 97.9% | ||
| Q1 24 | -1943.4% | — | ||
| Q4 23 | -2756.2% | — |
每股收益(稀释后)
RNA
SLAI
| Q3 25 | $-1.27 | — | ||
| Q2 25 | $-1.21 | $-0.01 | ||
| Q1 25 | $-0.90 | — | ||
| Q4 24 | $-0.80 | — | ||
| Q3 24 | $-0.65 | — | ||
| Q2 24 | $-0.65 | $0.02 | ||
| Q1 24 | $-0.79 | — | ||
| Q4 23 | $-0.80 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $350.2M | $1.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.9B | $43.8M |
| 总资产 | $2.1B | $69.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
RNA
SLAI
| Q3 25 | $350.2M | — | ||
| Q2 25 | $243.9M | $1.2M | ||
| Q1 25 | $254.2M | — | ||
| Q4 24 | $219.9M | — | ||
| Q3 24 | $370.2M | — | ||
| Q2 24 | $575.8M | $2.3M | ||
| Q1 24 | $471.4M | — | ||
| Q4 23 | $185.1M | — |
股东权益
RNA
SLAI
| Q3 25 | $1.9B | — | ||
| Q2 25 | $1.2B | $43.8M | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.2B | $45.9M | ||
| Q1 24 | $830.9M | — | ||
| Q4 23 | $500.8M | — |
总资产
RNA
SLAI
| Q3 25 | $2.1B | — | ||
| Q2 25 | $1.4B | $69.1M | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.3B | $63.3M | ||
| Q1 24 | $951.5M | — | ||
| Q4 23 | $628.6M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-156.2M | $-17.0M |
| 自由现金流经营现金流 - 资本支出 | $-156.9M | $-17.0M |
| 自由现金流率自由现金流/营收 | -1257.6% | -154.2% |
| 资本支出强度资本支出/营收 | 5.7% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-592.3M | — |
8季度趋势,按日历期对齐
经营现金流
RNA
SLAI
| Q3 25 | $-156.2M | — | ||
| Q2 25 | $-199.7M | $-17.0M | ||
| Q1 25 | $-124.8M | — | ||
| Q4 24 | $-99.9M | — | ||
| Q3 24 | $-65.6M | — | ||
| Q2 24 | $-65.0M | $-12.1M | ||
| Q1 24 | $-70.4M | — | ||
| Q4 23 | $16.5M | — |
自由现金流
RNA
SLAI
| Q3 25 | $-156.9M | — | ||
| Q2 25 | $-203.0M | $-17.0M | ||
| Q1 25 | $-128.6M | — | ||
| Q4 24 | $-103.8M | — | ||
| Q3 24 | $-67.3M | — | ||
| Q2 24 | $-65.5M | — | ||
| Q1 24 | $-71.3M | — | ||
| Q4 23 | $15.6M | — |
自由现金流率
RNA
SLAI
| Q3 25 | -1257.6% | — | ||
| Q2 25 | -5277.1% | -154.2% | ||
| Q1 25 | -8174.3% | — | ||
| Q4 24 | -3491.0% | — | ||
| Q3 24 | -2881.8% | — | ||
| Q2 24 | -3204.6% | — | ||
| Q1 24 | -2012.3% | — | ||
| Q4 23 | 713.1% | — |
资本支出强度
RNA
SLAI
| Q3 25 | 5.7% | — | ||
| Q2 25 | 86.9% | 0.0% | ||
| Q1 25 | 238.6% | — | ||
| Q4 24 | 131.7% | — | ||
| Q3 24 | 72.9% | — | ||
| Q2 24 | 26.0% | — | ||
| Q1 24 | 25.8% | — | ||
| Q4 23 | 39.4% | — |
现金转化率
RNA
SLAI
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -0.64× | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RNA
暂无分部数据
SLAI
| Data center | $6.5M | 59% |
| Cryptocurrency mining | $4.6M | 41% |